| B2M | beta-2 microglobulin |
| BEAMing | beads, emulsion, amplification, magnetics |
| CAPP-seq | cancer personalized profiling by deep sequencing |
| cfDNA | cell-free DNA |
| CIN | chromosomal instability |
| ddPCR | digital droplet PCR |
| FCGR | fibroblast growth factor receptor |
| FDA | Food and Drug Administration |
| FISH | fluorescence in situ hybridization |
| GC | gastric cancer |
| GEA | gastroesophageal adenocarcinoma |
| Her2 | human epidermal growth factor 2 |
| IHC | immunohistochemistry staining |
| MRD | minimal residual disease |
| MSI | microsatellite instability |
| NGS | next-generation sequencing |
| RT PCR | real-time PCR |
| TCGA | The Cancer Genome Atlas research project |
| UMI | unique molecular identifyer |
| VEGFR2 | vascular endothelial growth factor receptor-2 |
| WES | whole exome sequencing |